Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multi-protein complex involved in ALS interactome
- Molecular classification
- Protein complex
01
Overview
The "multi-protein complex involved in the ALS interactome" refers to a dynamic assembly of proteins that are functionally and physically interconnected, playing key roles in the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Key components include TDP-43, FUS, Ataxin-2, OPTN, UBQLN2, and C9orf72. These proteins participate in transient complexes that regulate RNA metabolism, protein homeostasis, stress granule dynamics, cytoskeletal organization, and cell survival. Targeting these multi-protein assemblies offers new therapeutic avenues for ALS.
02
Mechanism of action
Modulation of protein-protein interactions within the complex; modulation of chaperone activity; disruption of pathological aggregation.
03
Biological functions
RNA processing and regulationProtein quality control via ubiquitin-proteasome systemStress granule formation under cellular stress conditionsCytoskeleton reorganization
04
Disease associations
Neurodegenerative diseaseAmyotrophic Lateral Sclerosis (ALS)
05
Safety considerations
Potential for off-target effects due to the involvement of core complex components in multiple cellular processes.Complexity of targeting protein-protein interactions.
Beyond the preview
Go deeper on Multi-protein complex involved in ALS interactome.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Multi-protein complex involved in ALS interactome.